1Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009.CA Cancer [ J ]. Clin,2009,59 (4) : 225 - 249.
2Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor [ J ]. Cancer Res, 1979,39 (10) : 3861 - 3865.
3Fisher B, Gunduz N, Coyle J, et al. Presence of a growths- timulating factor in serum following primary tumor removal in mice[ J]. Cancer Res, 1989,49 (8) : 1996 - 2001.
4Fisher B, Gunduz N, Saffer EA. Influence of the interval be- tween primary tumor removal and chemotherapy on kinetics and growth of metastases [ J ]. Cancer Res, 1983,43 (4) : 1488 - 1492.
5Rastogi, Anderson SJ, Bear HD, et al. preoperative chemo- therapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B - 18 and B -27. [J]. Clin On- col,2008,26(5) :778 - 785.
6Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 [ J]. Ann Oncol.2009.20(8): 1319 - 1329.
8Van Nes JGH, Johanna GH, Putter H, et al. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow - up; clinical and translational results from the E ORTC trial 10902 [ J ]. Breast Cancer Res Treat,2009, 115(1) :101 - 113.
9Eisenhauer EA, Theraase P, Bogaerts J, et al. New response evaluation criteria in solid tulnours: revised RECIST guide- line(version 1.1) [J]. Eur J Cancer,2009,45 (2) :228 - 247.
10Chagpar AB, Middleton LP, Sahin AA, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy [ J ]. Ann Surg, 2006,243 (2) :257 - 264.
10Kurosumi M. Significance of histopathological evaluation in primary therapy for breast cancer--recent trends in primary modality with pathological complete response (pCR) as endpoint. Breast Cancer, 2004, 11 (2) : 139-147.
1TAKEDA D, NITTA H, TAKAHARA T, et al. Effect of preoper- ative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume[J]. World J Surg Oncol, 2013, 11(1): 65.
2YO0 SY, KIM JS, SUNG KW, et al. The degree of tumor vol- ume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma[J]. Cancer, 2013, 119(3): 656-664.
3Jemal A, Bray F, Center MM et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61 (2) :69 - 90.
